Publications by authors named "R Kallio"
Article Synopsis
- - This study analyzed the long-term survival rates of gastric cancer patients in Finland who underwent total or partial gastrectomy along with either splenectomy (removal of the spleen) or spleen preservation from 2005 to 2016.
- - Data from 2,196 patients were examined, revealing a 5-year survival rate of 38.7% for patients with minor spleen injury, 39.7% for those with splenectomy due to injury, and 30.8% for splenectomy due to cancer, indicating that the method of spleen management significantly impacted survival outcomes.
- - The results suggest that patients undergoing splenectomy for oncological reasons had worse survival rates compared to those
Article Synopsis
- Patients with ruptured gastrointestinal stromal tumors (GIST) tend to have a worse prognosis and limited information exists on the effect of adjuvant imatinib on their survival.
- A study analyzed the recurrence-free (RFS) and overall survival (OS) of 358 patients with localized GIST, 20% of whom had reported ruptures, finding that those with ruptures experienced lower RFS and OS compared to those without ruptures.
- The study concluded that while adjuvant imatinib for 3 years didn’t significantly enhance survival for ruptured GIST patients compared to 1 year, those with specific genetic mutations showed improved OS with longer treatment.
Background: The purpose of this study was to examine the rates of 90-day anastomotic complications and other postoperative complications after total or partial gastrectomy with antecolic versus retrocolic reconstruction in a population-based setting.
Methods: This population-based nationwide retrospective cohort study included all patients undergoing total or partial gastrectomy for gastric adenocarcinoma in Finland in 2005-2016, with follow-up until 31 December 2019. Logistic regression provided odds ratios (ORs) with 95% confidence intervals (CIs) of 90-day mortality.
Background: This study aimed to examine the rate of delayed emptying and other 90-day postoperative complications after total, subtotal, and distal gastrectomies for gastric adenocarcinoma in a population-based setting.
Methods: This study included all patients who underwent total, subtotal, or distal gastrectomy for gastric cancer in Finland in 2005-2016, with follow-up until December 31, 2019. Logistic regression provided the odds ratios with 95% CIs of 90-day mortality.
Background And Purpose: The CardioSwitch-study demonstrated that patients with solid tumors who develop cardiotoxicity on capecitabine or 5-fluorouracil (5-FU) treatment can be safely switched to S-1, an alternative fluoropyrimidine (FP). In light of the European Medicines Agency approval of S-1 in metastatic colorectal cancer (mCRC), this analysis provides more detailed safety and efficacy information, and data regarding metastasectomy and/or local ablative therapy (LAT), on the mCRC patients from the original study.
Materials And Methods: This retrospective cohort study was conducted at 12 European centers.